Sharon Shacham
2013
In 2013, Sharon Shacham earned a total compensation of $7.3M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 1,498% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $129,342 |
---|---|
Option Awards | $6,771,948 |
Salary | $380,507 |
Other | $10,225 |
Total | $7,292,022 |
Shacham received $6.8M in option awards, accounting for 93% of the total pay in 2013.
Shacham also received $129.3K in non-equity incentive plan, $380.5K in salary and $10.2K in other compensation.
Rankings
In 2013, Sharon Shacham's compensation ranked 746th out of 12,286 executives tracked by ExecPay. In other words, Shacham earned more than 93.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 746 | 94th |
Manufacturing | 243 | 95th |
Chemicals And Allied Products | 66 | 96th |
Drugs | 41 | 97th |
Pharmaceutical Preparations | 37 | 96th |
Shacham's colleagues
We found two more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2013.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019